|
DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,400 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices. |
Tradename: SILENOR
Summary for Tradename: SILENOR
|
| Pharmacology for Tradename: SILENOR
| ||||||||||
Clinical Trials for: SILENORSafety and Efficacy of Ramelteon and Doxepin in Subjects With Chronic Insomnia Status: Completed Condition: Sleep Initiation and Maintenance Disorders Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy Status: Recruiting Condition: Head and Neck Cancer; Mucositis; Oral Complications of Radiation Therapy; Pain Effect of Doxepin and Nortriptyline on Irritable Bowel Syndrome Status: Completed Condition: Irritable Bowel Syndrome The Treatment of Insomnia in Patients With HIV Disease Status: Completed Condition: HIV Infections; Insomnia Treatments for Insomnia in Patients With Parkinson's Disease Status: Recruiting Condition: Parkinson's Disease; Insomnia Treatment-Resistant Depression, Hippocampus Atrophy and Serotonin Genetic Polymorphism Status: Completed Condition: Major Depression Courtesy of ClinicalTrials.org See more clinical trials for this drug | ||||||||||||
Glossary
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Product | Substance | Delist_Flag | Patent Expiration | Exclusivity Expiration | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pernix Theraps Llc | SILENOR | doxepin hydrochloride | TABLET; ORAL | 022036 | Mar 17, 2010 | RX | No | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pernix Theraps Llc | SILENOR | doxepin hydrochloride | TABLET; ORAL | 022036 | Mar 17, 2010 | RX | No | 5,502,047 | <disabled> | <disabled> | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pernix Theraps Llc | SILENOR | doxepin hydrochloride | TABLET; ORAL | 022036 | Mar 17, 2010 | RX | No | 5,585,115 | Y | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pernix Theraps Llc | SILENOR | doxepin hydrochloride | TABLET; ORAL | 022036 | Mar 17, 2010 | RX | No | 5,725,884 | Y | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The preview shows a limited data set. Complete access is available with a Subscription | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Paragraph IV activity for: SILENOR
| Drugname | Dosage | Strength | RLD | Submissiondate |
| doxepin hydrochloride | Tablets | 3 mg and 6 mg | Silenor | 9/16/2010 |
« Back to Dashboard
DrugPatentWatch Archives
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Connect with Social Media:
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639
`abc
